CRISPR screening tool pinpoints new therapeutic target to treat acute myeloid leukemia

By | August 18, 2021
A CRISPR screening tool identified a new therapeutic target to treat acute myeloid leukemia (AML) that has the potential to leave patients with fewer side effects than current approaches, according to a new study from Penn Medicine published online in Molecular Cell.